Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03345264 · ClinicalTrials.gov registry record · NA
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
A NA study of Cancer-related Problem/Condition and Fertility, sponsored by American Cancer Society.
- Completed
- Registry status
- NA
- Development phase
- 361
- Enrollment target
- 1
- Study location
NCT03345264: Completed NA study of Cancer-related Problem/Condition and Fertility, sponsored by American Cancer Society.
NCT03345264 is a NA study of Cancer-related Problem/Condition and Fertility that has completed, run by American Cancer Society. The registered enrollment target is 361 participants, above the 78-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (363% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03345264, a NA study of Cancer-related Problem/Condition and Fertility, has completed, sponsored by American Cancer Society.
- COMPLETED
- Registry status
- NA
- Development phase
- 361 participants
- Enrollment target
- 1
- Study location
Study Summary
Concerns with sexual health and fertility are common among cancer patients, survivors and their partners. Literature reviews suggest that over 60% of survivors have reproductive health problems yet fewer than 20% get professional help. This study will test the uptake, use and effectiveness of online, interactive self-help programs for men and women with cancer. Participants in the study will receive up to 6 months of access to the self-help programs without charge. Navigation through the programs can be personalized by setting goals and following links to the most relevant information. The programs cover all cancer sites and common treatments, explaining sexual and fertility side effects. Programs also include step-by-step cognitive behavioral self-help exercises, guidance on available medical treatment options, decision aids, and video stories with actual survivors as well as vignettes with actors. Information for same-sex couples is included. Programs include suggestions on how partners can work together to cope with sexual or fertility issues. The primary hypothesis is that participants will report improvements in sexual function and satisfaction from baseline to 3-month follow-up. Secondary hypotheses will investigate whether more extensive use of the program is associated with better outcomes (dose-response effect) and whether the intervention also improves secondary outcomes such as anxiety, depression, relationship satisfaction, and seeking medical help. Analyses from the data will investigate how many people who are informed of the study decide to participate (uptake), as well as how often participants visit the program and which parts are used most. Both the male and female programs have previously been shown to help cancer survivors and partners in published clinical trials. Participants will be encouraged to invite a sexual partner to join the study, but that will be optional. Partners will be able to be linked for statistical analysis through their uni
Primary Outcome
Construct: Sexual function and satisfaction in men; Total Score Range: 0-33; Higher values represent a better outcome
Conditions Studied
Interventions
- BEHAVIORAL Online, interactive self-help program
Study Locations (1)
Texas
- Will2Love, LLC - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2018-12-11 |
| Phase | NA |
What the finished NCT03345264 record still lists
NCT03345264 is an interventional study that assigns participants to a tested intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap, above the 78-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (363% higher).
The record links to 3 conditions, with Cancer-related Problem/Condition appearing as the primary indexed condition, and to 1 intervention - of which Online, interactive self-help program is the first listed.
NCT03345264 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03345264 about?
NCT03345264 is a clinical study titled "The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study". Concerns with sexual health and fertility are common among cancer patients, survivors and their partners. Literature reviews suggest that over 60% of survivors have reproductive health problems yet fewer than 20% get professional help. This study will test the uptake, use and effectiveness of online...
What is the current status of trial NCT03345264?
This trial is currently completed. It is a NA study. The enrollment target is 361 participants. The study started on 2017-10-02. Estimated completion is 2018-12-11.
What conditions does trial NCT03345264 study?
This clinical trial studies the following conditions: Cancer-related Problem/Condition, Fertility, Sexuality.
What interventions are being tested in trial NCT03345264?
The interventions under investigation include: Online, interactive self-help program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03345264?
This trial is sponsored by American Cancer Society, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03345264 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer-related Problem/Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03345264's enrollment target sits among peer trials
361 1st of 10 higher than 10 of 10 other Cancer-related Problem/Condition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer-related Problem/Condition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
RECRUITING · NA
-
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Virtual Exercise Program to Reduce Cancer Related Fatigue
ACTIVE NOT RECRUITING · NA
-
Systematic Light Exposure for Fatigue in Breast Cancer Patients
COMPLETED · NA
-
Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue
COMPLETED · NA
-
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI